Log In
Print this Print this

Votrient, pazopanib

Also known as: formerly Armala, GW786034

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionBroad-spectrum inhibitor of VEGF and other tyrosine kinases
Molecular Target Vascular endothelial growth factor (VEGF) receptor 1 (FLT1) (VEGFR-1) ; Vascular endothelial growth factor (VEGF) receptor 2 (VEGFR-2) (KDR/Flk-1)
Mechanism of ActionVascular endothelial growth factor (VEGF) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today